Michael Liebowitz
Affiliations: | Columbia / New York State Psychiatric Institute |
Google:
"Michael Liebowitz"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Donald Klein | research scientist | Columbia / New York State Psychiatric Institute |
Children
Sign in to add trainee| Ashley L Greene | research assistant | ||
| Daniel Scott Schechter | grad student | 1994-2005 | Columbia / New York State Psychiatric Institute |
| Eric Hollander | post-doc | Columbia / New York State Psychiatric Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fedgchin M, Trivedi M, Daly EJ, et al. (2019) Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). The International Journal of Neuropsychopharmacology |
| Liebowitz MR, Careri J, Blatt K, et al. (2017) Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder. Depression and Anxiety |
| Rodebaugh TL, Levinson CA, Langer JK, et al. (2017) The structure of vulnerabilities for social anxiety disorder. Psychiatry Research. 250: 297-301 |
| Liebowitz MR, Hanover R, Draine A, et al. (2016) Effect of as-needed use of intranasal PH94B on social and performance anxiety in individuals with social anxiety disorder. Depression and Anxiety |
| Careri JM, Draine AE, Hanover R, et al. (2015) A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder. The Primary Care Companion For Cns Disorders. 17 |
| Cohen JN, Potter CM, Drabick DA, et al. (2015) Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs. Psychiatry Research. 228: 65-71 |
| Menatti AR, Weeks JW, Carleton RN, et al. (2015) The Social Interaction Phobia Scale: Continued support for the psychometric validity of the SIPS using clinical and non-clinical samples. Journal of Anxiety Disorders. 32: 46-55 |
| Williams MT, Farris SG, Turkheimer EN, et al. (2014) The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder. Journal of Anxiety Disorders. 28: 553-8 |
| Liebowitz MR, Salman E, Nicolini H, et al. (2014) Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorder. The American Journal of Psychiatry. 171: 675-82 |
| Heimberg RG, Hofmann SG, Liebowitz MR, et al. (2014) Social anxiety disorder in DSM-5. Depression and Anxiety. 31: 472-9 |